Role of Topical Application of Growth Factors on Periodontal Repair ()
1. Introduction
Regeneration of periodontal structures lost during periodontal diseases constitutes a complex biological process regulated among others by interactions between cells and growth factors.
The histological feature of a periodontal wound comprises 1) the gingival epithelium, 2) the gingival connective tissue, 3) the periodontal ligament, and the hard tissue components such as 4) alveolar bone and 5) cementum or dentin on the dental root surface [1] .
Growth factors are biologically active polypeptides affecting the proliferation, chemotaxis and differentiation of cells from epithelium, bone and connective tissue. They express their action by binding to specific cell-surface receptors present on various target cells including osteoblasts, cementoblasts and periodontal ligament fibroblasts [2] [3] . It is also found that several growth factors in addition to cytokines and enzymes, of host origin appear to hold the greatest promise as valuable biomarkers in assessing the health of periodontal tissue, and its role in periodontial healing [4] -[6] . Growth factors mediate many events associated with turnover, repair and regeneration of periodontal tissues. Vascular Endothelial Growth Factor (VEGF). Over the last two decades researchers have demonstrated that VEGF is a key regulator of physiological and pathological angiogenesis, because it induces endothelial cell proliferation, stimulates angiogenesis and increases vascular permeability [7] . Transforming growth factor-β (TGF-β) exhibits both pro-inflammatory and anti-inflammatory properties besides its ability to stimulate synthesis of ECM molecules and to inhibit the breakdown of ECM, it has been intensively evaluated in relation to periodontial healing [8] .
The observation that growth factors participate in all cell functions led to exogenous application during periodontal tissue repair high lightened on the present research aim to use growth factors as an alternative therapeutic approach to periodontal treatment.
2. Materials and Methods
2.1. Materials
VEGF165Aprotein (Rat) (ab51967), lyophilised form From abcam company.
TGF beta 1 protein (Active) (ab50036), lyophilised form From abcam company.
2.2. Study Design
All experimental procedures were carried out in accordance with the ethical principles of animal experimentation and according to the National Research Council’s guide for the care and use of laboratory animals. In this experimental study fifty four male Albino rats, weighting (300 - 400) gram, aged (6 - 8) months were used and maintained under control conditions of temperature, drinking and food consumption. The animals were subjected for non surgical operation of distal sides of both lower anterior teeth (right side was considered as experimental site, while left be the control one).
The animals were divided into control and experimental group, the experimental group was subdivided into following groups according to the applicated growth factors.
A. Contol group the periodontium defect treated with 1 µm of normal saline and its number represented the all number of the following experimental groups as the left side of each animal considered to be the control.
B. Experimental group includes:
· Group 1 contains (18) rats, the periodontium defect treated with 1 µm of VEGF.
· Group 2 contains (18) rats the periodontium defect treated with 1 µm of TGF-β1.
· Group 3 contains (18) rats, the periodontium defect treated with 1 µm combination of (VEGF & TGF-β1).
2.3. Methods
2.3.1. Assessment for the Subgingival Depth to Create a Periodontium Defect
Before starting the experiment, histologic and radiographic examinations were done to ten samples of lower jaw carrying the central teeth of normal intact rats (excluded from the designed number) to get a data base on the estimation of a proper sub gingival depth related to rats that allowed and supported the study to create a periodontium defect includes alveolar bone, cementum and periodontal ligament (Figure 1).
2.3.2. Non Surgical Technique
The non surgery was performed under a well sterilized condition and gentle technique. Every animal was weighted to calculate the dose of general anesthesia that was given to it. The general anesthesia was induced by Intra muscular injection of xylazine 2% (0.4 mg/kg B.W.), plus keta mine HCL 50 mg (40 mg/kg-B.W.). Then
Figure 1. Radiographic view for lower anterior teeth shows cutting (0.2 mm) from alveolar bone (arrow) while other side still intact (arrow head).
the animal was placed on the surgical table and the surgical towel was placed under the site of the operation. Using Cavitron Ultrasonic Scaler with a stopper to 0.2 mm (depth assess from our present data) and with focused spray design that inserts direct water down into the pocket in which it helps to flush away debris., periodotium defect was made. Removing thin cementum layer, alveolar bone layer and tearing in periodontal ligament for both distal sides of lower anterior teeth, experimental and control sites. After operation a radiographic films were taken to confirm our work (Figure 1).
Drying the area by air, then applied of growth factor (VEGF, TGF-β1, combination) 1 µm, while normal saline 1 µm was used for control. The animals were scarified at intervals 3, 7, 14 day postoperatively, using over dose anesthesia. Six animals for each period. Jaw were removed, and the lower jaw carrying anterior teeth was dissected .
2.3.3. Preparation of the Specimens
The specimens were immediately fixed in 10% freshly prepared neutral buffered formalin for 3 days, then decalcified by formic acid-sodium citrate solution, which was prepared freshly from 2 solutions:
Solution A: 125 cc formic acid 90%. 125 cc distilled water.
Solution B: 50 mg sodium citrate. 250 cc distilled water.
Then passing to all laboratory procedures till getting slides stained by hematoxylin and eosin (H & E) and examined under light microscope for histological evaluation.
2.3.4. Histometry Evaluation of Histological Findings
A. Periodontal ligament width. Measured the distance of periodontal ligament present in cervical area (only) passed from the alveolar bone to cementum.
B. Junctional epithelial length (JEP) measured as the distance between the most coronal to the most apical aspects of the epithelium along the root.
C. Newly formed cementum and bone width (in cervical area), measured from the reversal line separated the old from the new one, to its final edge of the newly apposite tissue.
The above measures were obtained through Olympus light microscope equipped with eyepiece ocular scale micrometer at 20× magnification D. Rate of maturation of newly bone was estimated by counting the number of osteon in five histological sections per animal and in five microscopic fields for each section, in cervical region, at 40× magnification [9] .
2.3.5. Statistic Analysis
A. Descriptive data analysis. B. Inferential data analysis.
3. Results and Discussion
3.1. Histological Findings
Histological results for control group illustrated deposition of osteoid tissue against alvrolar bone, Seconday junctional epithelia and fibrous junctional are detected in Figures 2, 3, 4, while for VEGF group osteoclast detected early at 3 day and then immature bone apposed against the alveolar bone with identification of reversed
Figure 2. View for osteoid tissue (OST), alveolar bone (AB) in control group at 7 days. H & E ×40.
Figure 3. View for periodontium (control) at 14 day duration, shows establishment of secondary junctional epithelia (arrow), gingiva (G) H & E ×20
Figure 4. view illustrates fibrous junctional site (arrow) in control. H & E ×20.
line. The new cellular cementum, periodontal ligament and junctional epithelia reestablished at 14 day, Figures 5, 6, 7, 8, 9. TGF B1 group shows gingivae with active mitotic feature for basal cell and apposition of cellular cemntum is detected, Figures 10, 11, while combination group shows mature bone newly formed separated by demarked line from the old bone, Figure 12.
Figure 5. View for granulation tissue (GT) with presences of osteoclast (arrow) in VEGF group at 3 day. H & E ×20.
Figure 6. Histological view for periodontium treated with VEGF at 14 days, shows immature bone (IMB) overlay alveolar crest (AC). H & E ×20.
Figure 7. Magnifying view for VEGF group shows immature bone (IMB), alveolar bone (AB) with presences of reversal line (arrow). H & E ×20.
Figure 8. View illustrates reestablishment of periodontal ligament (PDL), cellular cementum (CC) and alveolar bone (AB) in VEGF group. H & E ×20.
Figure 9. View for establishment of junctional epithelia (arrow) In VEGF group. H & E ×40.
Figure 10. View for gingival tissue in TGF group, at 3 day, shows mitotic activity of basal cell. H & E ×20.
Figure 11. Magnifying view for cellular cementum (CC) in TGF group. H & E ×40.
Figure 12. View for periodontium treated with combination after curette at 14 day duration shows new bone formation (NB) separated from old bone (OB) by reversal line (arrow head) H & E ×20.
The present results conclude the followings:
a. All study groups (control, VEGF treated group, TGFβ1 treated group and combination (VEGF & TGF) group), show organized blood clot and formation of granulation tissue at 3 day period.
b. Edematous gingival identified in control and VEGF groups, While TGF and combination groups illustrate gingiva with mitotic basal cells. This result may contributed to that VEGF cause hyperpermeability, which allows fluid to leak from the intravascular space into the parenchyma tissue, which causes vasogenic edema and increased interstitial fluid pressure [10] , while results demonstrated that the maintenance and proliferation of germ stem cells and their progeny depends upon TGF B1 [11] .
c. Osteoclast cell identify early in VEGF only, while osteoid tissue recognized early in combination group. These findings suggest that VEGF may regulate osteoclast differentiation as well as angiogenesis [12] , while TGF-beta has been shown to be one of the most important regulators in chondrogenesis and osteogenesis [13] .
d. Mature bone detected in combination group only, at 14 day period, other groups show immature form. This finding demonstrated the mechanisms in which TGF-β1 interacts with bone component cells, such as osteoblasts, osteoclasts, mesenchymal stem cells, and hematopoietic stem cells, in concert with other cytokines and hormones [14] .
e. Secondary junctional epithelia recognized in control group only, at 14 day period.
Our study suggest that this observation may be a tissue response to injury, which may lead to fiber interdigitation in curette area that lack junctional epithelia. This result is in agreement with findings of Tal & Stahl [15] .
3.2. Histometrical Analysis
Bar chart and Stem-Leaf (Explorer) Plots for mean values of Periodontal ligament width, Junctional epithelial length, new cementum width, new bone width and rate of maturation are listed in (Table 1; Figures 13 and 14) The histometric data records the followings.
1. The mean value of amount of new bone and the mean of the length of junctional epithelia is showed to be higher in VEGF group, this agrees with a previous study [16] in which reduction in width of an intrabony periodontal defect was accompanied by a long junctional epithelia.
2. The mean of periodontal ligament width and mean of rate of bone maturation are reported to be higher in
Table 1. Multiple comparisons among all pairs for histometry of histological findings at 14 days parameters at the studied trials.
(*) HS: Highly Significant at P < 0.01; NS: Non Significant at P > 0.05.
combination group. This is due to effect of both VEGF and TGF for enhancement of cellular proliferation by TGF and nourishment of the developing repaired area by newly blood vessels that formed in response to VEGF action.
4. Conclusion
The present study suggested that all experimental groups with growth factors application show repaired periodontium higher than control groups and it seems that single use of VEGF in injured periodontium is a more powerful tool in regeneration than TGFβ1 or their combination.
Abbreviations
VEGF: vascular endothelial growth factor PDL: periodontal ligament TGF-β1: transforming growth factor CC: cellular cementum AB: alveolar bone